3-hydroxymethyl-2,2,5,5-tetramethylpyrroline-n-oxyl and Acquired Metabolic Diseases, Brain

3-hydroxymethyl-2,2,5,5-tetramethylpyrroline-n-oxyl has been researched along with Acquired Metabolic Diseases, Brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Morinobu, S; Ueda, Y; Yokoyama, H	1

Other Studies

1 other study(ies) available for 3-hydroxymethyl-2,2,5,5-tetramethylpyrroline-n-oxyl and Acquired Metabolic Diseases, Brain

Article	Year
EPRI to estimate the in vivo intracerebral reducing ability in adolescent rats subjected to neonatal isolation. Journal of magnetic resonance imaging : JMRI, 2006, Volume: 23, Issue:5 Topics: Analysis of Variance; Animals; Animals, Newborn; Blood-Brain Barrier; Brain; Brain Diseases, Metabolic; Cyclic N-Oxides; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Imaging, Three-Dimensional; Oxidation-Reduction; Pyrrolidines; Rats; Rats, Sprague-Dawley; Restraint, Physical; Social Isolation; Stress, Psychological; Time Factors	2006

Article

Year

EPRI to estimate the in vivo intracerebral reducing ability in adolescent rats subjected to neonatal isolation.

Journal of magnetic resonance imaging : JMRI, 2006, Volume: 23, Issue:5

Topics: Analysis of Variance; Animals; Animals, Newborn; Blood-Brain Barrier; Brain; Brain Diseases, Metabolic; Cyclic N-Oxides; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Imaging, Three-Dimensional; Oxidation-Reduction; Pyrrolidines; Rats; Rats, Sprague-Dawley; Restraint, Physical; Social Isolation; Stress, Psychological; Time Factors

2006